EMULSION APRAPOLE DPN852

Hazard statements (CLP)

H351, H373

Code

Statements

H351

Suspected of causing cancer

SECTION 2: Hazards identification

Classification of the substance or mixture CARCINOGENICITY - Category 2 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) (central nervous system (CNS), kidneys, liver) - Category 2

Signal word

Warning

Hazard statements

Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. (central nervous system (CNS), kidneys, liver)

Precautionary statements

General : Read label before use. Keep out of reach of children. If medical advice is needed, have product container or label at hand.

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves. Wear protective clothing. Wear eye or face protection. Do not breathe vapor.

Response

Get medical attention if you feel unwell. IF exposed or concerned: Get medical attention.

Storage

Store locked up.

Disposal

Dispose of contents and container in accordance with all local, regional, national and international regulations.

Supplemental label elements

Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. Emits toxic fumes when heated.

Ingredient(s) with unknown acute toxicity

46.3% (Oral), 46.3% (Dermal), 46.3% (Inhalation)

2.1 Classification of the substance or mixture

CARCINOGENICITY - Category 2 substance or mixture SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) (central nervous system (CNS), kidneys, liver) - Category 2